NVDQ
T-Rex 2X Inverse NVIDIA Daily Target ETF
stockBATSETF
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the United States and internationally. The company offers SPY Elite, a fluorescence imaging system that enables surgeons performing open procedures, such as breast and other reconstruction, gastrointestinal, and cardiothoracic surgery, to visualize microvascular blood flow and perfusion in tissue intraoperatively. It also provides PINPOINT endoscopic fluorescence imaging systems; LUNA fluorescence angiography system that provides clinicians with real-time visualization of tissue perfusion in patients; and Dermacell, a decellularized regenerative human tissue matrix that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds. Novadaq Technologies Inc. has alliances with Intuitive Surgical, Inc.; LifeNet Health; MAQUET Getinge Group; and Arthrex, Inc. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.12 | 2026-09-28 | -6.90% | -3.355 |
| 1M | 8.13 | 2026-09-04 | -7.01% | -2.816 |
| 3M | 12.45 | 2026-07-06 | -39.28% | -3.779 |
| 6M | 16.90 | 2026-04-06 | -55.27% | -3.730 |
| 1Y | 18.74 | 2025-10-06 | -59.65% | -3.706 |
| 2Y | 87.80 | 2024-10-04 | -91.39% | — |
T-Rex 2X Inverse NVIDIA Daily Target ETF (BATS:NVDQ) stock price today is $7.56, and today's volume is 969,425. NVDQ is down 2.577% today. The 30 day average volume is 6.50M. NVDQ market cap is $17.54M with 2.32M shares outstanding.